Import restrictions and reduction in the variety of respiratory sprays/prices reached 5 million Tomans

Restrictions on imports and reduction in the variety of respiratory sprays in the market, along with a tenfold jump in prices, have made it more difficult for patients with lung diseases to access the right medicine.

Restrictions on imports and reduction in the variety of respiratory sprays in the market, along with a tenfold jump in prices, have made it more difficult for patients with lung diseases to access the right medicine.

The import restriction and reduction in the variety of respiratory sprays in the market, along with the jump in prices several tens of times, have made it more difficult for patients with lung diseases to access the right medicine; According to an associate professor of Shahid Beheshti University of Medical Sciences, the price of sprays, which used to cost 60 to 200 thousand tomans with insurance, has now reached one and a half to 5 million tomans.

According to Ambassador Arjan's report, Kashfizadeh said on the sidelines of the 12th National Congress of Lung Diseases, Special Care and Sleep: "The variety of respiratory sprays is not as wide as before and we are facing restrictions on the import of this type of medicine."

According to him, the limitation of the available options has made patients unable to have a good variety of medicines as in the past. This issue becomes especially important when the patient shows complications to a particular spray and the doctor has to change his medicine.

Referring to the difference in side effects of respiratory sprays, Kashfizadeh explained that all these drugs do not have the same side effects, and in case of problems, it may be necessary to change the patient's spray. But when the variety of drugs available in the market decreases, the doctor's hand to choose a suitable alternative is also closed.

In such a situation, the issue is not just the lack of one or more drugs; Patients may find it more difficult to find the right spray for their condition. This issue is especially important for people who need continuous treatment of respiratory diseases.

Import restrictions are not the only problem of the respiratory sprays market; The price of these drugs has also increased drastically. Referring to the price growth, Kashfizadeh said: The cost of providing respiratory sprays, which used to be around 60 to 200 thousand tomans with insurance, has now reached one and a half to 5 million tomans.

This price increase puts significant financial pressure on patients who need constant use of the spray to control their disease. In fact, the patient is faced with more limited options for choosing medicine and has to pay more for its preparation. Of course, the amount of price increase in all sprays is not the same, and for an accurate comparison, the type of medicine, the price at two points in time, and the patient's share after applying the insurance must be known. However, the simultaneity of import restrictions, reduction of variety and increase in prices has highlighted the need to review the supply status of these drugs and the extent of their insurance coverage; Especially for patients for whom regular access to inhalation spray is an integral part of their treatment process.

By publishing a new framework for monitoring agent-based artificial intelligence in the health system, the American Medical Association emphasized the necessity of evaluating functional evidence, determining the limits of authority, effective monitoring and determining the responsibility for possible errors of this technology in patient care.

A new study of 8,783 Canadian adults found that those who ate the most highly processed foods were about 40 percent more likely to have signs of silent brain damage; Changes that may occur without detectable problems in memory and thinking.

The secretary of the Pain Research and Study Association in Iran emphasized that an accurate diagnosis of the cause of back pain is a prerequisite for choosing a treatment method, and said: Many patients with back pain and lumbar disc problems do not necessarily need surgery, and if the treatment method is chosen correctly, non-surgical solutions can be used to control pain and return the patient to daily activities.

The director of the Food and Drug Organization's health product safety monitoring group, emphasizing the dangers of arbitrary use of contraceptive pills, said: Taking these drugs without a doctor's prescription, especially in people with risk factors, can have serious and even life-threatening side effects.

Contrary to popular belief, self-administered exercise to lower high blood sugar in people who use insulin can be very dangerous, a sports medicine expert said.

The head of the specialized group for the management of tuberculosis, leprosy and acute respiratory infections of the Ministry of Health, stating that about 80% of the cases of tuberculosis detected last year were pulmonary, said: Considering the important role of pulmonary tuberculosis in the transmission of the disease in the society, the rapid identification of these patients and the timely initiation of treatment is one of the main priorities of the country's tuberculosis control program.

When do colds, flu, sore throat and bronchitis not need antibiotics? Read the guide table for proper use and side effects of self-treatment.

Obstetrics and Gynecology specialist and infertility specialist while explaining endometriosis disease and the hypotheses of this disease, explained about the treatment methods of this disease.